Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1004530358;30359;30360 chr2:178704237;178704236;178704235chr2:179568964;179568963;179568962
N2AB972829407;29408;29409 chr2:178704237;178704236;178704235chr2:179568964;179568963;179568962
N2A880126626;26627;26628 chr2:178704237;178704236;178704235chr2:179568964;179568963;179568962
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: TTG
  • RefSeq wild type template codon: AAC
  • Domain: Ig-85
  • Domain position: 57
  • Structural Position: 138
  • Q(SASA): 0.0786
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/W rs776484795 -1.715 1.0 None 0.843 0.765 0.878366613624 gnomAD-3.1.2 6.57E-06 None None None None N None 0 0 0 0 0 None 0 0 1.47E-05 0 0
L/W rs776484795 -1.715 1.0 None 0.843 0.765 0.878366613624 gnomAD-4.0.0 3.04479E-06 None None None None N None 0 0 None 0 0 None 0 0 3.61477E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.9693 likely_pathogenic 0.9859 pathogenic -2.734 Highly Destabilizing 0.999 D 0.713 prob.delet. None None None None N
L/C 0.9551 likely_pathogenic 0.9846 pathogenic -2.144 Highly Destabilizing 1.0 D 0.83 deleterious None None None None N
L/D 0.9996 likely_pathogenic 0.9997 pathogenic -3.565 Highly Destabilizing 1.0 D 0.896 deleterious None None None None N
L/E 0.9972 likely_pathogenic 0.9981 pathogenic -3.249 Highly Destabilizing 1.0 D 0.878 deleterious None None None None N
L/F 0.6649 likely_pathogenic 0.8276 pathogenic -1.613 Destabilizing 1.0 D 0.792 deleterious None None None None N
L/G 0.9935 likely_pathogenic 0.9963 pathogenic -3.343 Highly Destabilizing 1.0 D 0.868 deleterious None None None None N
L/H 0.9904 likely_pathogenic 0.9951 pathogenic -3.091 Highly Destabilizing 1.0 D 0.863 deleterious None None None None N
L/I 0.3389 likely_benign 0.5204 ambiguous -0.901 Destabilizing 0.999 D 0.642 neutral None None None None N
L/K 0.9937 likely_pathogenic 0.9952 pathogenic -2.121 Highly Destabilizing 1.0 D 0.867 deleterious None None None None N
L/M 0.3576 ambiguous 0.5129 ambiguous -1.146 Destabilizing 1.0 D 0.789 deleterious None None None None N
L/N 0.9974 likely_pathogenic 0.998 pathogenic -2.823 Highly Destabilizing 1.0 D 0.897 deleterious None None None None N
L/P 0.9992 likely_pathogenic 0.9997 pathogenic -1.503 Destabilizing 1.0 D 0.895 deleterious None None None None N
L/Q 0.9869 likely_pathogenic 0.9923 pathogenic -2.484 Highly Destabilizing 1.0 D 0.89 deleterious None None None None N
L/R 0.9877 likely_pathogenic 0.9921 pathogenic -2.144 Highly Destabilizing 1.0 D 0.881 deleterious None None None None N
L/S 0.9974 likely_pathogenic 0.999 pathogenic -3.385 Highly Destabilizing 1.0 D 0.861 deleterious None None None None N
L/T 0.9893 likely_pathogenic 0.9949 pathogenic -2.906 Highly Destabilizing 1.0 D 0.798 deleterious None None None None N
L/V 0.4408 ambiguous 0.6661 pathogenic -1.503 Destabilizing 0.999 D 0.648 neutral None None None None N
L/W 0.9487 likely_pathogenic 0.9814 pathogenic -2.1 Highly Destabilizing 1.0 D 0.843 deleterious None None None None N
L/Y 0.9585 likely_pathogenic 0.9779 pathogenic -1.875 Destabilizing 1.0 D 0.832 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.